Interv Akut Kardiol. 2015;14(4):148-153

Cardiogenic and septic shock in acute myocardial infarction

Milan Hromádka1, Thomas Karvunidis2, Richard Rokyta1,
Kardiologické oddělení, Komplexní kardiovaskulární centrum, Fakultní nemocnice Plzeň,
1 Lékařská fakulta v Plzni, Univerzita Karlova v Praze
2 I. interní klinika, Fakultní nemocnice Plzeň, Lékařská fakulta v Plzni, Univerzita Karlova v Praze

Cardiogenic shock is a serious complication of acute myocardial infarction with a high mortality rate. A prompt and correct diagnosis

and early revascularisation are the cornerstones of the treatment. Supportive therapy, both pharmacological and nonpharmacological,

including the replacement of failing organs, is another important factor. Cardiogenic shock most frequently occurs in extensive acute

myocardial infarction with ST segment elevation (STEMI). Coincidence with systemic infection, sepsis, or even septic shock is relatively

common. These complications increase the risk and incidence of (multi)organ damage (MODS), patient morbidity and mortality as well

as the costs of medical care and prolong the lenght of hospital stay.

Keywords: myocardial infarction, cardiogenic shock, sepsis, organ dysfunction

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hromádka M, Karvunidis T, Rokyta R. Cardiogenic and septic shock in acute myocardial infarction. Interv Akut Kardiol. 2015;14(4):148-153.
Download citation

References

  1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006; 295: 2511-2515. Go to original source... Go to PubMed...
  2. Babaev A, Frederick PD, Pasta DJ, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005; 294: 448-454. Go to original source... Go to PubMed...
  3. Czarnecki A, Welsh RC, Yan RT, et al. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute CoronarEvents (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol. 2012; 28: 40-47. Go to original source... Go to PubMed...
  4. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med. 1999; 341: 625-634. Go to original source... Go to PubMed...
  5. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013; 369(18): 1726-1734. Go to original source... Go to PubMed...
  6. Angus D, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013; 369(9): 840-845. Go to original source... Go to PubMed...
  7. Labovitz AJ, Noble VE, Bierig M, et al. Focused cardiac ultrasound in the emergent setting: a consensus statement of the American Society of Echocardiogrephy and American College of Emergent Physicians. J Am Soc Echocardiogr. 2010; 23(12): 1225-1230. Go to original source... Go to PubMed...
  8. Vincent JL, Rhodes A, Perel A, et al. Clinical review: Update on hemodynamic monitoring - a consensus of 16. Crit Care. 2011; 15(4): 229. Go to original source... Go to PubMed...
  9. Lee KS, Abbas AE, Khandheria BK, et al. Echocardiographic assessment of right heart hemodynamic parameters. J Am Soc Echocardiogr. 2007; 20: 773-782. Go to original source... Go to PubMed...
  10. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler paging in the estimation of left ventricular filling pressures: A komparative simultaneous Doppler-cathetrization study. Circulation. 2000; 102: 1788-1794. Go to original source... Go to PubMed...
  11. Lamia B, Ochagavia A, Monnet X, et al. Echocardiographic prediction of volume responsiveness in critically ill patients with spontaneously breathing activity. Intensive Care Med. 2007; 33: 1125-1132. Go to original source... Go to PubMed...
  12. Robson SC, Murray A, Peart I, et al. Reproducibility of cardiac output measurement by cross sectional and Doppler echocardiography. Br Heart J. 1988; 59: 680-684. Go to original source... Go to PubMed...
  13. Shah MR, Hasselblad V, Stevenson LW, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA. 2005; 294: 1664-1670. Go to original source... Go to PubMed...
  14. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2011; 32: 2999-3054. Go to original source... Go to PubMed...
  15. Widimský P, Rokyta R, Šťásek, et.al. Acute coronary syndromes with ongoing myocardial ischemia (ACS with OMI) versus acute coronary syndromes without ongoing ischemia (ACS without OMI): The new classification of acute coronary syndromes should replace old classification based on ST segment elevation presence or absence - Expert consesnsus statement of the Czech Society of Cardiology. Cor et Vasa. 2013; 54: e225-e227. Go to original source...
  16. Hussain F, Philipp RK, Ducas RA, Elliott J, Dzavik V, Jassal DS, Tam JW, Roberts D, Garber PJ, Ducas J. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators. Cathetr Cardiovasc Interv. 2011; 78: 540-548. Go to original source... Go to PubMed...
  17. Bernat I, Abdelaal E, Plourde G, et al. Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock. Am Heart J. 2013; 165: 338-343. Go to original source... Go to PubMed...
  18. Vojáček J, Jánksý P, Janota T. Třetí univerzální definice infarktu myokardu. Cor et Vasa. 2013; 55: e228-e235. Go to original source...
  19. Rokyta R, Matějovič M. Léčba pacientů s nejtěžšími formami sepse z pohledu medicíny založené na důkazech. Co by měl kardiolog-intenzivista znát ? Intervenční a akutní kardiologie 2006; 5: 216-223.
  20. Del Pace S, Boddi M, Rasoini R, et al. Acute infection-inflammation and coronary stent thrombosis: an observational study. Intern Emerg Med. 2010; 5(2): 121-126. Go to original source... Go to PubMed...
  21. Toušek P, Rokyta R, Tesařová J, et al. Routine upfront abciximab versus standard periprocedural therapy in patiens undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study. Acute Card Care. 2011; 13: 116-122. Go to original source... Go to PubMed...
  22. Rokyta R, Pechman V, Toušek P, et al. Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study. Exp Clin Cardiol. 2013; 18: 81-84.
  23. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33: 2569-2619. Go to original source... Go to PubMed...
  24. Kouraki K, Schneider S, Uebis R, et al. Characteristics and clinical outcome of 458 patients with acute myocardial infarction requiring mechanical ventilation. Results of the BEAT registry of the ALKK-study group. Clin Res Cardiol. 2011; 100: 235-239. Go to original source... Go to PubMed...
  25. Widimský P, Kala P, Rokyta R. Summary of the 2012 ESC Guidelines for the management of acute myocardial infarction in patiens presenting with ST-segment elevations. Prepared by the Czech Society of Cardiology. Cor et Vasa. 2012; 54: e273-289. Go to original source...
  26. Perez P, Kimmoun A, Blime V, et al. Increasing Mean Arterial Pressure in Cardiogenic Shock Secondary to Myocardial Infarction: Effects on Hemodynamics and Tissue Oxygenation. PEREZ, Pierre; KIMMOUN, Antoine; BLIME, Vincent; LEVY, Bruno Less Shock. post acceptance, Feb 2014. Go to original source...
  27. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012; 33: 1787-1847. Go to original source... Go to PubMed...
  28. De Backer D, Biston P, Devriendt J. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362: 779-789. Go to original source... Go to PubMed...
  29. Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamin for patiens with acute decompensated heart silure: the SURVIVE Randomized Trial. JAMA. 2007; 297: 1883-1891. Go to original source... Go to PubMed...
  30. Rokyta R., Pechman V. The effects of levosimendan on global haemodynamics in patiens with cardiogenic shock. Neuro Endocrinol Lett. 2006; 27: 121-127.
  31. Fuhrmann JT, Schmeisser A, Schulze MR, et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2008; 36: 2257-2266. Go to original source... Go to PubMed...
  32. Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock. Final 12-month results of the randomised IntraAortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) Trial. Lancet. 2013; 382: 1638-1645. Go to original source... Go to PubMed...
  33. Tsao NW, Shih ChM, Yeh JS. Extracorporeal membrane oxygenation - assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. Journal of Critical Care. 2012; 27: 530.e1-530.e11. Go to original source... Go to PubMed...
  34. Monti G, Herrera M, Kindgen-Milles D, et al. The DOse Response Multicentre International Collaborative Initiative (DO-RE-MI). Contrib Nephrol. 2007; 156: 434-443. Go to original source... Go to PubMed...
  35. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007; 3: CD003773. Go to original source... Go to PubMed...
  36. Schneider AG, Bellomo R, Baqshaw SM, et al. Choice of renal replacement therapy modality and Dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2013; 39(6): 987-997. Go to original source... Go to PubMed...
  37. Ricci Z, Ronco C. Renal replacement therapy in the critically ill: getting it right. Curr Opin Crit Care. 2012; 18(6): 607-612. Go to original source... Go to PubMed...
  38. Baqshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007; 9(1): 60-68. Go to original source... Go to PubMed...
  39. Sampath S, Moran JL, Graham PL, et al. The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med. 2007; 35(11): 2516-2524. Go to original source... Go to PubMed...
  40. Karajala V, Mansour W, Kellum JA. Diuretics in acute kidney injury. Minerva Anestesiol. 2009; 75(5): 251-257. Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.